UNLABELLED: Hepatocyte nuclear factor 4 alpha (HNF4alpha), a member of the nuclear receptor superfamily, is essential for liver function and is linked to several diseases including diabetes, hemophilia, atherosclerosis, and hepatitis. Although many DNA response elements and target genes have been identified for HNF4alpha, the complete repertoire of binding sites and target genes in the human genome is unknown. Here, we adapt protein binding microarrays (PBMs) to examine the DNA-binding characteristics of two HNF4alpha species (rat and human) and isoforms (HNF4alpha2 and HNF4alpha8) in a high-throughput fashion. We identified approximately 1400 new binding sequences and used this dataset to successfully train a Support Vector Machine (SVM) model that predicts an additional approximately 10,000 unique HNF4alpha-binding sequences; we also identify new rules for HNF4alpha DNA binding. We performed expression profiling of an HNF4alpha RNA interference knockdown in HepG2 cells and compared the results to a search of the promoters of all human genes with the PBM and SVM models, as well as published genome-wide location analysis. Using this integrated approach, we identified approximately 240 new direct HNF4alpha human target genes, including new functional categories of genes not typically associated with HNF4alpha, such as cell cycle, immune function, apoptosis, stress response, and other cancer-related genes. CONCLUSION: We report the first use of PBMs with a full-length liver-enriched transcription factor and greatly expand the repertoire of HNF4alpha-binding sequences and target genes, thereby identifying new functions for HNF4alpha. We also establish a web-based tool, HNF4 Motif Finder, that can be used to identify potential HNF4alpha-binding sites in any sequence.
UNLABELLED: Hepatocyte nuclear factor 4 alpha (HNF4alpha), a member of the nuclear receptor superfamily, is essential for liver function and is linked to several diseases including diabetes, hemophilia, atherosclerosis, and hepatitis. Although many DNA response elements and target genes have been identified for HNF4alpha, the complete repertoire of binding sites and target genes in the human genome is unknown. Here, we adapt protein binding microarrays (PBMs) to examine the DNA-binding characteristics of two HNF4alpha species (rat and human) and isoforms (HNF4alpha2 and HNF4alpha8) in a high-throughput fashion. We identified approximately 1400 new binding sequences and used this dataset to successfully train a Support Vector Machine (SVM) model that predicts an additional approximately 10,000 unique HNF4alpha-binding sequences; we also identify new rules for HNF4alpha DNA binding. We performed expression profiling of an HNF4alpha RNA interference knockdown in HepG2 cells and compared the results to a search of the promoters of all human genes with the PBM and SVM models, as well as published genome-wide location analysis. Using this integrated approach, we identified approximately 240 new direct HNF4alphahuman target genes, including new functional categories of genes not typically associated with HNF4alpha, such as cell cycle, immune function, apoptosis, stress response, and other cancer-related genes. CONCLUSION: We report the first use of PBMs with a full-length liver-enriched transcription factor and greatly expand the repertoire of HNF4alpha-binding sequences and target genes, thereby identifying new functions for HNF4alpha. We also establish a web-based tool, HNF4 Motif Finder, that can be used to identify potential HNF4alpha-binding sites in any sequence.
Authors: Alvaro Rada-Iglesias; Ola Wallerman; Christoph Koch; Adam Ameur; Stefan Enroth; Gayle Clelland; Kenneth Wester; Sarah Wilcox; Oliver M Dovey; Peter D Ellis; Vicki L Wraight; Keith James; Rob Andrews; Cordelia Langford; Pawandeep Dhami; Nigel Carter; David Vetrie; Fredrik Pontén; Jan Komorowski; Ian Dunham; Claes Wadelius Journal: Hum Mol Genet Date: 2005-10-12 Impact factor: 6.150
Authors: T Tanaka; S Jiang; H Hotta; K Takano; H Iwanari; K Sumi; K Daigo; R Ohashi; M Sugai; C Ikegame; H Umezu; Y Hirayama; Y Midorikawa; Y Hippo; A Watanabe; Y Uchiyama; G Hasegawa; Pc Reid; H Aburatani; T Hamakubo; J Sakai; M Naito; T Kodama Journal: J Pathol Date: 2006-04 Impact factor: 7.996
Authors: Duncan T Odom; Robin D Dowell; Elizabeth S Jacobsen; Lena Nekludova; P Alexander Rolfe; Timothy W Danford; David K Gifford; Ernest Fraenkel; Graeme I Bell; Richard A Young Journal: Mol Syst Biol Date: 2006-05-02 Impact factor: 11.429
Authors: F Garibaldi; C Cicchini; A Conigliaro; L Santangelo; A M Cozzolino; G Grassi; A Marchetti; M Tripodi; L Amicone Journal: Cell Death Differ Date: 2011-12-02 Impact factor: 15.828
Authors: Stanley Y Shaw; David M Blodgett; Maggie S Ma; Elizabeth C Westly; Paul A Clemons; Aravind Subramanian; Stuart L Schreiber Journal: Proc Natl Acad Sci U S A Date: 2010-12-23 Impact factor: 11.205
Authors: Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek Journal: Proc Natl Acad Sci U S A Date: 2012-01-30 Impact factor: 11.205
Authors: Karthikeyani Chellappa; Poonamjot Deol; Jane R Evans; Linh M Vuong; Gang Chen; Nadege Briançon; Eugene Bolotin; Christian Lytle; Meera G Nair; Frances M Sladek Journal: Elife Date: 2016-05-11 Impact factor: 8.140
Authors: Alice Kiselyuk; Seung-Hee Lee; Suzette Farber-Katz; Mingjun Zhang; Sonalee Athavankar; Tom Cohen; Anthony B Pinkerton; Mao Ye; Paul Bushway; Adam D Richardson; Heather A Hostetler; Mariam Rodriguez-Lee; Li Huang; Benjamin Spangler; Layton Smith; Jennifer Higginbotham; John Cashman; Hudson Freeze; Pamela Itkin-Ansari; Marcia I Dawson; Friedhelm Schroeder; Yong Cang; Mark Mercola; Fred Levine Journal: Chem Biol Date: 2012-07-27